Skip to main content
. 2017 Feb 8;103(7):538–545. doi: 10.1136/heartjnl-2016-310210

Table 1.

Performance of a clinical decision rule where those with a 10% or greater 10-year cardiovascular risk are considered positive for CVD (ie, at a high enough risk to require treatment, such as with statins): Glaswegian women in SHHEC

Truth
Clinical decision rule CVD No CVD Total
Treat (risk ≥10%) 124 (62%) 584 708
Do not treat (risk <10%) 76 1517 (72%) 1593
Total 200 2101 2301

Risk was estimated from a logistic regression model, including age, systolic blood pressure, total and high-density lipoprotein-cholesterol, diabetes and smoking status.

Sensitivity (true positive frequency)=124/200=0.620% or 62.0%.

Specificity (true negative frequency)=1517/2101=0.722% or 72.2%.

Note: This ignores censoring and bias from self-testing.

CVD, cardiovascular disease; SHHEC, Scottish Heart Health Extended Cohort.